Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
C. Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E. de Melker, Mirjam J. Knol, Susan J.M. Hahné, Susan van den Hof, View ORCID ProfileBrechje de Gier
doi: https://doi.org/10.1101/2023.12.12.23299855
C. Henri van Werkhoven
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
2Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
Anne-Wil Valk
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Bente Smagge
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Hester E. de Melker
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Mirjam J. Knol
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Susan J.M. Hahné
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Susan van den Hof
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Brechje de Gier
1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
Article usage
Posted December 13, 2023.
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
C. Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E. de Melker, Mirjam J. Knol, Susan J.M. Hahné, Susan van den Hof, Brechje de Gier
medRxiv 2023.12.12.23299855; doi: https://doi.org/10.1101/2023.12.12.23299855
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
C. Henri van Werkhoven, Anne-Wil Valk, Bente Smagge, Hester E. de Melker, Mirjam J. Knol, Susan J.M. Hahné, Susan van den Hof, Brechje de Gier
medRxiv 2023.12.12.23299855; doi: https://doi.org/10.1101/2023.12.12.23299855
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2909)
- Dermatology (249)
- Emergency Medicine (437)
- Epidemiology (12681)
- Forensic Medicine (10)
- Gastroenterology (824)
- Genetic and Genomic Medicine (4538)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2898)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (919)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4304)
- Nursing (233)
- Nutrition (633)
- Oncology (2251)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1192)
- Primary Care Research (492)
- Public and Global Health (6888)
- Radiology and Imaging (1517)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (208)
- Urology (178)